The BimSR implant was established to focus on drug delivery directly to the iris and ciliary human body, thus altering matrix metalloprotein manufacturing and minimizing extracellular matrix in outflow tissues[sixty five]–[sixty six]. By upregulating this pathway, drug distribution is restricted to the pertinent tissue targets As a result lowerin